Analyst consensus rating
Sotera Health Analyst Rating: Buy
SHC is rated Buy by 9 analysts with a $22.72 target. As of 2026-08-28.
Direct answer
Sotera Health's consensus rating is Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $22.72.
Forecast evidence checked August 28, 2026.
Get free Sotera Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $19.36
- Average price target
- $22.72
- High price target
- $25.00
- Low price target
- $18.00
- Low target gap
- -7%
- Target upside
- +17.4%
- High target gap
- +29.1%
- Target range width
- 36.2%
- Consensus rating
- Buy
- Analysts
- 9
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Sotera Health?
Sotera Health has a verified Buy consensus. The same dataset has an average price target of $22.72.
How far are Sotera Health's low and high targets from the recorded price?
The low target implies -7%, while the high target implies +29.1%.
How many analysts are included in Sotera Health's consensus?
The verified consensus includes 9 analysts.
How is Sotera Health's target upside or downside calculated?
The average target of $22.72 is divided by the recorded price of $19.36, then one is subtracted to produce +17.4%. This does not guarantee a future return.
When was Sotera Health's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.